UK: +44 (0) 1925 737 237 US: +1 (307) 264 1572 info@perfectusbiomed.com

 A joint project for Perfectus Biomed Group, Magnitude Biosciences, and the University of Kent aims to provide an assay to aid research on infections caused by Pseudomonas aeruginosa, delivering a solution to accelerate wound care research and reduce the reliance on mammalian testing.

The project focuses on developing an industrial whole organism assay for biofilms made by pathogenic bacteria without the use of laboratory rodents or mammals. The collaboration from Magnitude Biosciences, Perfectus Biomed Group and the University of Kent sees an exciting combination of knowledge and expertise sharing. Perfectus Biomed Group have extensive experience designing accredited and customisable biofilm testing methods. Magnitude Biosciences are specialists in customised C. elegans studies, which accelerate research by offering an alternative to rodent and mammalian testing.  University of Kent has expertise in developing new models to study host-microbe interactions and state-of-the-art facilities to monitor biofilms.

Companies producing chronic infection solutions currently test using in vitro models such as solid surface tests. Through this project Magnitude Biosciences, Perfectus Biomed and the University of Kent will develop colour-based assays to monitor biofilm formation by the pathogen Pseudomonas aeruginosa in the transparent nematode Caenorhabditis elegans (C. elegans). Assays using fluorescent markers and health readouts will be a faster and more cost-effective alternative to using rodents or mammals. This assay will provide data that better mimics clinical scenarios to support chronic infection research without the ethical implications associated with rodent and other mammalian testing.

Pseudomonas aeruginosa causes a large proportion of the infections that occur in hospitals such as chronic wound infection and chronic respiratory infections. Research that leads to products that improve and resolve these infections is critical for the development of life-changing and lifesaving treatments for patients.

For more information on our testing capabilities please contact us to discuss.

Press contacts:

Jennie Ritchie,

Marketing Assistant Perfectus Biomed, info@perfectusbiomed.com 

www.perfectusbiomed.com

UK – 01925 737 237 USA – +1 (307) 2641572

Mira Nair

Head of Marketing, Magnitude Biosciences mira@magnitudebiosciences.com

 www.magnitudebiosciences.com

 

Sam Wood

Press & Public Relations Officer, Communications, Engagement, University of Kent

s.wood-700@kent.ac.uk

https://www.kent.ac.uk/

 

 

 

COVID-19
Get in Touch